Celyad Announces First Quarter 2020 Financial Results and Recent Business Highlights
MONT-SAINT-GUIBERT, Belgium, May 07, 2020 (GLOBE NEWSWIRE) -- Celyad (Euronext Brussels and Paris, and Nasdaq: CYAD), a clinical-stage biopharmaceutical company focused on the development of CAR-T cell therapies, today announced an update on operational …